Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04931368
Title OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma (OptiMATe)
Acronym OptiMATe
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Klinikum Stuttgart
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.